Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Virtual Congress 2020

Ipsen - What does the changing treatment landscape for aRCC mean for patient care: An expert discussion

Shifting perceptions in the first-line treatment of aRCC & Panel discussion

Date

22 Sep 2020

Session

Ipsen - What does the changing treatment landscape for aRCC mean for patient care: An expert discussion

Presenters

Toni Choueiri

Authors

T.K. Choueiri

Author affiliations

  • Medical Oncology Dept., Dana Farber Cancer Institute, 2215 - Boston/US

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Welcome and introduction

Presenter: Cristina Suarez

Session: Ipsen - What does the changing treatment landscape for aRCC mean for patient care: An expert discussion

Resources:

Webcast

Closing comments

Presenter: Cristina Suarez Rodriguez

Session: Ipsen - What does the changing treatment landscape for aRCC mean for patient care: An expert discussion

Resources:

Webcast

Live Q&A - 28 September 2020 - 15:30-16:00

Presenter: Cristina Suarez

Session: Ipsen - What does the changing treatment landscape for aRCC mean for patient care: An expert discussion

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.